May 16, 2018
Dr. Reddy's Laboratories is recalling 8160 bottles of metoprolol succinate extended-release tablets, USP, 100 mg (NDC 55111-468-01), after a 75-mg clopidogrel tablet was found in 1 of the bottles. The recall appears in the May 16, 2018, US Food and Drug Administration (FDA) Enforcement Report.
The recall affects 100-tablet bottles of metoprolol succinate extended-release from batch C706254, which has an August 2019 expiration date. The bottles were distributed nationwide.
Dr. Reddy's Laboratories voluntarily issued the recall April 23, 2018. On May 9, 2018, the FDA designated it Class II. The classification communicates that use of the medication could cause temporary or medically reversible adverse health consequences, with a remote probability of serious harm.
Extended-release metoprolol succinate is a prescription beta blocker used to treat chest pain, heart failure, and hypertension. Clopidogrel is a prescription blood thinner used to prevent stroke, heart attack, and other heart issues.
For more Pharmacy Learning Network articles, visit the homepage
To learn about Pharmacy Learning Network Live meetings, click here